P. Quarato

541 total citations
9 papers, 472 citations indexed

About

P. Quarato is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, P. Quarato has authored 9 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in P. Quarato's work include Lipoproteins and Cardiovascular Health (4 papers), Plant biochemistry and biosynthesis (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). P. Quarato is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Plant biochemistry and biosynthesis (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). P. Quarato collaborates with scholars based in Italy, Netherlands and United States. P. Quarato's co-authors include Alberto Corsini, R. Fumagalli, Rodolfo Paoletti, Stefano Bellosta, Lorenzo Arnaboldi, Nicola Ferri, Franco Bernini, M. Canavesi, M. Raiteri and R. Paoletti and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

P. Quarato

9 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Quarato Italy 7 305 173 106 98 69 9 472
Tetsuya Totsuka Japan 10 187 0.6× 97 0.6× 48 0.5× 52 0.5× 94 1.4× 14 366
Ray Rosa United States 5 225 0.7× 102 0.6× 55 0.5× 74 0.8× 112 1.6× 5 434
Toshiyuki Nishikido Japan 11 246 0.8× 114 0.7× 119 1.1× 70 0.7× 61 0.9× 20 479
José Alfón Spain 10 163 0.5× 119 0.7× 69 0.7× 57 0.6× 99 1.4× 28 490
Shoji Katsuda Japan 11 245 0.8× 157 0.9× 110 1.0× 70 0.7× 19 0.3× 21 466
Latha Paka United States 12 108 0.4× 200 1.2× 77 0.7× 87 0.9× 58 0.8× 17 518
Mark A. Spahr United States 8 289 0.9× 132 0.8× 55 0.5× 128 1.3× 79 1.1× 14 481
Gaëlle Asset France 11 408 1.3× 197 1.1× 53 0.5× 73 0.7× 73 1.1× 24 717
Melissa E. MacDonald Canada 13 176 0.6× 172 1.0× 65 0.6× 57 0.6× 92 1.3× 22 528
Donna G. Virgil United States 13 188 0.6× 150 0.9× 57 0.5× 77 0.8× 66 1.0× 17 488

Countries citing papers authored by P. Quarato

Since Specialization
Citations

This map shows the geographic impact of P. Quarato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Quarato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Quarato more than expected).

Fields of papers citing papers by P. Quarato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Quarato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Quarato. The network helps show where P. Quarato may publish in the future.

Co-authorship network of co-authors of P. Quarato

This figure shows the co-authorship network connecting the top 25 collaborators of P. Quarato. A scholar is included among the top collaborators of P. Quarato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Quarato. P. Quarato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Quarato, P., et al.. (1998). Picotamide, an antithromboxane agent, inhibits the migration and proliferation of arterial myocytes. European Journal of Pharmacology. 355(1). 77–83. 22 indexed citations
2.
Bellosta, Stefano, Franco Bernini, Nicola Ferri, et al.. (1998). Direct vascular effects of HMG-CoA reductase inhibitors. Atherosclerosis. 137. S101–S109. 199 indexed citations
3.
Raiteri, M., Lorenzo Arnaboldi, Paul McGeady, et al.. (1997). Pharmacological Control of the Mevalonate Pathway: Effect on Arterial Smooth Muscle Cell Proliferation. Journal of Pharmacology and Experimental Therapeutics. 281(3). 1144–1153. 83 indexed citations
4.
Corsini, Alberto, Lorenzo Arnaboldi, P. Quarato, et al.. (1997). [Pharmacological control of biosynthesis pathway of mevalonate: effect on the proliferation of arterial smooth muscle cells].. PubMed. 191(2). 169–94. 2 indexed citations
5.
Corsini, Alberto, F. Bernini, P. Quarato, et al.. (1996). Non-Lipid-Related Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors. Cardiology. 87(6). 458–468. 77 indexed citations
6.
Corsini, Alberto, P. Quarato, Maria Rosa Accomazzo, et al.. (1996). Effect of the New Calcium Antagonist Lercanidipine and Its Enantiomers on the Migration and Proliferation of Arterial Myocytes. Journal of Cardiovascular Pharmacology. 28(5). 687–694. 42 indexed citations
7.
Raiteri, M., Lorenzo Arnaboldi, P. Quarato, et al.. (1995). [The pharmacology of the statins: the evidence of a direct antiatherosclerotic action].. PubMed. 10 Suppl. 35S–42S. 2 indexed citations
8.
Corsini, Alberto, et al.. (1995). Effects of 26-Aminocholesterol, 27-Hydroxycholesterol, and 25-Hydroxycholesterol on Proliferation and Cholesterol Homeostasis in Arterial Myocytes. Arteriosclerosis Thrombosis and Vascular Biology. 15(3). 420–428. 36 indexed citations
9.
Corsini, Alberto, P. Quarato, M. Raiteri, et al.. (1993). Effect of the Nifedipine-Atenolol Association on Arterial Myocyte Migration and Proliferation. Pharmacological Research. 27(4). 299–308. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026